中文版 | English
题名

CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin

作者
通讯作者Long, Ying; Wang, Jigang; Li, Zhijie
发表日期
2022-11-26
DOI
发表期刊
ISSN
1226-4601
EISSN
2055-7124
卷号26期号:1
摘要
["Background: It is highly desirable to develop new therapeutic strategies for gastric cancer given the low survival rate despite improvement in the past decades. Cadherin 17 (CDH17) is a membrane protein highly expressed in cancers of digestive system. Nanobody represents a novel antibody format for cancer targeted imaging and drug delivery. Nanobody targeting CHD17 as an imaging probe and a delivery vehicle of toxin remains to be explored for its theragnostic potential in gastric cancer.","Methods: Naive nanobody phage library was screened against CDH17 Domain 1-3 and identified nanobodies were extensively characterized with various assays. Nanobodies labeled with imaging probe were tested in vitro and in vivo for gastric cancer detection. A CDH17 Nanobody fused with toxin PE38 was evaluated for gastric cancer inhibition in vitro and in vivo.","Results: Two nanobodies (Al and E8) against human CDH17 with high affinity and high specificity were successfully obtained. These nanobodies could specifically bind to CDH17 protein and CDH17-positive gastric cancer cells. E8 nanobody as a lead was extensively determined for tumor imaging and drug delivery. It could efficiently co-localize with CDH17-positive gastric cancer cells in zebrafish embryos and rapidly visualize the tumor mass in mice within 3 h when conjugated with imaging dyes. E8 nanobody fused with toxin PE38 showed excellent anti-tumor effect and remarkably improved the mice survival in cell-derived (CDX) and patient-derived xenograft (PDX) models. The immunotoxin also enhanced the anti-tumor effect of clinical drug 5-Fluorouracil.","Conclusions: The study presents a novel imaging and drug delivery strategy by targeting CDH17. CDH17 nanobody-based immunotoxin is potentially a promising therapeutic modality for clinical translation against gastric cancer."]
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
资助项目
Basic and Applied Basic Research Foundation of GuangDong Province["2021A1515012164","2021A1515111188"] ; International Science and Technology Cooperation for Shenzhen Technology Innovation Plan[GJHZ20200731095411034] ; National Key Research and Development Program of China["2020YFA0908000","2022YFC2303600"] ; Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine[ZYYCXTDC-202002] ; Shenzhen Science and Technology Innovation Commission["JCYJ20210324115800001","JCYJ20210324114014039"] ; National Natural Science Foundation of China["82074098","81841001","82274182"]
WOS研究方向
Engineering ; Materials Science
WOS类目
Engineering, Biomedical ; Materials Science, Biomaterials
WOS记录号
WOS:000888816400002
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:14
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/417072
专题南方科技大学第一附属医院
作者单位
1.Jinan Univ, Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Hyperbar Med,Shenzhen Peoples Hosp,Clin Med, Shenzhen 518020, Guangdong, Peoples R China
2.Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin 300193, Peoples R China
3.Jinan Univ, Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Geriatr,Shenzhen Peoples Hosp,Clin Med Coll, Shenzhen 518020, Guangdong, Peoples R China
4.Wuhan Univ, Dept Hepatobiliary & Pancreat Surg, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China
5.Southern Med Univ, Nanfang Hosp, Clin Pharm Ctr, Guangzhou 510515, Guangdong, Peoples R China
6.Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China
7.Shenzhen Technol Univ, Coll Pharm, Shenzhen 518118, Peoples R China
8.Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518055, Guangdong, Peoples R China
9.Karolinska Inst, Dept Biosci & Nutr, S-14157 Stockholm, Sweden
10.Univ Hong Kong, Dept Chem, Pok Fu Lam, Hong Kong, Peoples R China
11.Shanxi Datong Univ, Sch Chem & Chem Engn, Xing Yun St, Datong 037009, Shanxi, Peoples R China
12.China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing 100700, Peoples R China
13.China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China
第一作者单位南方科技大学第一附属医院
通讯作者单位南方科技大学第一附属医院
第一作者的第一单位南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Ma, Jingbo,Xu, Xiaolong,Fu, Chunjin,et al. CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin[J]. Biomaterials Research,2022,26(1).
APA
Ma, Jingbo.,Xu, Xiaolong.,Fu, Chunjin.,Xia, Peng.,Tian, Ming.,...&Li, Zhijie.(2022).CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin.Biomaterials Research,26(1).
MLA
Ma, Jingbo,et al."CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin".Biomaterials Research 26.1(2022).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Ma, Jingbo]的文章
[Xu, Xiaolong]的文章
[Fu, Chunjin]的文章
百度学术
百度学术中相似的文章
[Ma, Jingbo]的文章
[Xu, Xiaolong]的文章
[Fu, Chunjin]的文章
必应学术
必应学术中相似的文章
[Ma, Jingbo]的文章
[Xu, Xiaolong]的文章
[Fu, Chunjin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。